YI Key Statistics, Chart & Performance
The current stock price of YI is 5.46 USD. In the past month the price increased by 38.5%. In the past year, price decreased by -3.79%.
YI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to YI. When comparing the yearly performance of all stocks, YI turns out to be only a medium performer in the overall market: it outperformed 60.04% of all stocks.
YI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to YI. Both the profitability and financial health of YI have multiple concerns.
YI Financial Highlights
Over the last trailing twelve months YI reported a non-GAAP Earnings per Share(EPS) of -1.18. The EPS increased by 97.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.82% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
YI Forecast & Estimates
YI Ownership
YI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MGRX | MANGOCEUTICALS INC | N/A | 7.65M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 4.21M |
Related stock screener links
About YI
Company Profile
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
Company Info
111 INC
3-4/F, No.295 Zuchongzhi Road, Pudong New Area
Shanghai SHANGHAI 201203 CN
CEO: Junling Liu
Employees: 1238
Phone: 862120536666
111 INC / YI FAQ
Can you describe the business of 111 INC?
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
What is the current price of YI stock?
The current stock price of YI is 5.46 USD. The price increased by 7.48% in the last trading session.
What is the dividend status of 111 INC?
YI does not pay a dividend.
What is the ChartMill technical and fundamental rating of YI stock?
YI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of YI stock?
111 INC (YI) operates in the Consumer Staples sector and the Consumer Staples Distribution & Retail industry.
Would investing in 111 INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on YI.